Rahmer Peter

See remarks

Rahmer Peter has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Aug 28, 2026.

On the most recent filing, Rahmer Peter is listed as See remarks at Relay Therapeutics, Inc. Inside the rolling window, Rahmer Peter reported no open-market purchases and 8 open-market sales totaling $1.5M in RLAY. The largest disclosed transaction in the window is a sale of 50,000 RLAY shares on Jun 30, 2026, worth $955K.

Companies traded

Other insiders at RLAY

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.5M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
RLAYSale$90KAug 28SEC ↗
RLAYSale$14KJul 30SEC ↗
RLAYSale$955KJul 2SEC ↗
RLAYSale$11KApr 30SEC ↗
RLAYSale$89KJan 29SEC ↗
RLAYSale$11KJan 29SEC ↗
RLAYSale$139KOct 30SEC ↗
RLAYSale$160KOct 30SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Rahmer Peter made?

Rahmer Peter has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.

Which companies does Rahmer Peter trade?

Rahmer Peter has filed SEC Form 4 disclosures for 1 company, including RLAY.

When was Rahmer Peter's most recent SEC Form 4 filing?

Rahmer Peter's most recent SEC Form 4 filing on Tracefour is dated Aug 28, 2026.

What is Rahmer Peter's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Rahmer Peter is listed as See remarks.

What is Rahmer Peter's total buy and sell value in the current window?

Inside the rolling retention window, Rahmer Peter bought $0 and sold $1.5M based on SEC Form 4 filings.

What was Rahmer Peter's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 50,000 RLAY shares on 2026-06-30, worth $955K, per SEC Form 4 filings.